Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01ERE
|
|||
| Drug Name |
ASP4345
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7; ICD-9: 331.83] | Phase 2 | [1] | |
| Company |
Astellas Pharma US Northbrook, IL
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03557931) A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.